Refine
Has Fulltext
- yes (24)
Is part of the Bibliography
- yes (24)
Year of publication
Document Type
- Journal article (24)
Language
- English (24)
Keywords
- B cells (3)
- adalimumab (3)
- rheumatoid arthritis (3)
- scleroderma (3)
- systemic sclerosis (3)
- Autologous hematopoietic stem cell transplantation (2)
- Systemic sclerosis (2)
- Th17 (2)
- antirheumatic agents (2)
- inflammation (2)
- memory B cells (2)
- regression analysis (2)
- treatment outcome (2)
- B cell culture (1)
- CMV reactivation (1)
- CP-690,550 (1)
- Clinical remission (1)
- DAS28 (1)
- DMARD (1)
- Drug-free remission (1)
- GCA (1)
- GRAID (1)
- Grave’s disease (1)
- HAQ (1)
- Infectious complications (1)
- Interleukin-10 (1)
- Medizin (1)
- Memory B cells (1)
- PMR (1)
- PROM’s (1)
- PU.1 (1)
- Rheumatoid Arthritis (1)
- Rituximab (1)
- S100A8/S100A9 (1)
- Scleroderma (1)
- Sjögren’s syndrome (1)
- Synovitis (1)
- T cells (1)
- Th9 (1)
- Tregs (1)
- Validation (1)
- [18F]FDG PET/CT (1)
- adverse events (1)
- arthritis (1)
- autoimmune disease (1)
- autoimmune encephalitis (1)
- autoimmunity (1)
- autologous hematopoietic stem cell transplantation (1)
- autologous stem cell transplantation (1)
- bile (1)
- c-reactive protein (1)
- calprotectin (1)
- care (1)
- chemokines (1)
- cirrhosis (1)
- clinical-practice (1)
- common variable immunodeficiency (1)
- common variable immunodeficiency (CVID) (1)
- contrast-enhanced ultrasound. (1)
- cytokines (1)
- cytotoxic T cells (1)
- discordance (1)
- disease comorbidities (1)
- disease-activity score (1)
- engraftment syndrome (1)
- fatigue (1)
- fever (1)
- genital warts (1)
- giant cell arteritis (1)
- health-assessment questionnaire (1)
- hepatitis C virus (1)
- human papillomavirus (1)
- immune cells (1)
- immunophenotyping (1)
- immunosuppression (1)
- inborn errors of immunity (IEIs) (1)
- inflammation marker (1)
- interleukin-9 (1)
- iohexol (1)
- janus kinase inhibitor (1)
- kidney function (1)
- liver diseases (1)
- methotrexate (1)
- methylation (1)
- minimally important difference (1)
- modified Rodnan skin score (mRSS) (1)
- mycophenolate (1)
- naïve B cells (1)
- neurology (1)
- physicians (1)
- plasma clearance (1)
- polymyalgia rheumatica (1)
- primary immunodeficiencies (1)
- primary immunodeficiency (1)
- renal function (1)
- renal perfusion (1)
- reported outcomes (1)
- rheumatoid (1)
- rheumatoid arhritis (1)
- risk factor analysis (1)
- rituximab (1)
- serum creatinine (1)
- suppression (1)
- tocilizumab (1)
- tocilizumab (IL-6 inhibitor) (1)
- validation (1)
- vasculature (1)
- vasculitis (1)
- γδ T cells (1)
Institute
- Medizinische Klinik und Poliklinik II (24)
- Kinderklinik und Poliklinik (3)
- Neurologische Klinik und Poliklinik (2)
- Frauenklinik und Poliklinik (1)
- Institut für Humangenetik (1)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (1)
- Klinik und Poliklinik für Nuklearmedizin (1)
- Pathologisches Institut (1)
Renal Perfusion in Scleroderma Patients Assessed by Microbubble-Based Contrast-Enhanced Ultrasound
(2012)
Abstract: Objectives: Renal damage is common in scleroderma. It can occur acutely or chronically. Renal reserve might already be impaired before it can be detected by laboratory findings. Microbubble-based contrast-enhanced ultrasound has been demonstrated to improve blood perfusion imaging in organs. Therefore, we conducted a study to assess renal perfusion in scleroderma patients utilizing this novel technique. Materials and Methodology: Microbubble-based contrast agent was infused and destroyed by using high mechanical index by Siemens Sequoia (curved array, 4.5 MHz). Replenishment was recorded for 8 seconds. Regions of interests (ROI) were analyzed in renal parenchyma, interlobular artery and renal pyramid with quantitative contrast software (CUSQ 1.4, Siemens Acuson, Mountain View, California). Time to maximal Enhancement (TmE), maximal enhancement (mE) and maximal enhancement relative to maximal enhancement of the interlobular artery (mE%A) were calculated for different ROIs. Results: There was a linear correlation between the time to maximal enhancement in the parenchyma and the glomerular filtration rate. However, the other parameters did not reveal significant differences between scleroderma patients and healthy controls. Conclusion: Renal perfusion of scleroderma patients including the glomerular filtration rate can be assessed using microbubble-based contrast media.